Auke P Verhaar
Overview
Explore the profile of Auke P Verhaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mommersteeg M, Nieuwenburg S, Wolters L, Roovers B, van Vuuren H, Verhaar A, et al.
United European Gastroenterol J
. 2023 Oct;
11(9):894-903.
PMID: 37854002
Background: Clarithromycin resistance of Helicobacter pylori (H. pylori) represents a major challenge in eradication therapy. In this study, we assessed if non-invasive stool tests can be used to verify successful...
2.
Janmaat V, Nesteruk K, Spaander M, Verhaar A, Yu B, Silva R, et al.
Nat Commun
. 2021 Jun;
12(1):3354.
PMID: 34099670
Barrett's esophagus in gastrointestinal reflux patients constitutes a columnar epithelium with distal characteristics, prone to progress to esophageal adenocarcinoma. HOX genes are known mediators of position-dependent morphology. Here we show...
3.
Liu P, Verhaar A, Peppelenbosch M
Trends Biochem Sci
. 2018 Nov;
44(1):64-74.
PMID: 30446376
Ankyrin repeat and suppressor of cytokine signaling (SOCS) box (Asb) proteins are ubiquitin E3 ligases. The subfamily of six-ankyrin repeat domain-containing Asb proteins (Asb5, Asb9, Asb11, and Asb13) is of...
4.
Yin Y, Chen S, Hakim M, Wang W, Xu L, Dang W, et al.
Antiviral Res
. 2018 Jun;
156:92-101.
PMID: 29920300
Rotavirus infection has emerged as an important cause of complications in organ transplantation recipients and might play a role in the pathogenesis of inflammatory bowel disease (IBD). 6-Thioguanine (6-TG) has...
5.
Kreijne J, van der Giessen J, Verhaar A, Peppelenbosch M, de Vries A, van der Woude C, et al.
J Clin Gastroenterol
. 2017 Dec;
53(5):395-397.
PMID: 29256991
No abstract available.
6.
Li J, Verhaar A, Pan Q, de Knegt R, Peppelenbosch M
Clin Exp Gastroenterol
. 2017 Sep;
10:203-209.
PMID: 28860836
Background And Aim: Caspase-cleaved cytokeratin 18 (CK18-Asp396) is a potential clinically useful biomarker in liver disease as it is released from hepatocytes during apoptosis. In this study, we investigated serum...
7.
Peppelenbosch M, Fuhler G, Verhaar A, van der Laan L
Curr Med Chem
. 2016 Dec;
24(9):928-936.
PMID: 28031008
Background: The body of biomedical literature on Vitamin D effector mechanisms in gastrointestinal biology and pathophysiology is rapidly expanding. Accordingly, new possibilities of vitamin D biology-based therapeutical intervention in gastroenterological...
8.
Utomo W, Janmaat V, Verhaar A, Cros J, Levy P, Ruszniewski P, et al.
Am J Cancer Res
. 2016 Sep;
6(8):1837-41.
PMID: 27648370
Identification of pancreatic cysts with malignant potential is important to prevent pancreatic cancer development. Integrity of cell free DNA (cfDNA) has been described as tumor biomarker, but its potential for...
9.
Verhaar A, Peppelenbosch M
Stem Cells Dev
. 2016 Feb;
25(7):572-3.
PMID: 26847629
No abstract available.
10.
Palles C, Chegwidden L, Li X, Findlay J, Farnham G, Giner F, et al.
Gastroenterology
. 2014 Dec;
148(2):367-78.
PMID: 25447851
Background & Aims: Barrett's esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found the risk to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome...